Podcasts about arpa h

agency workforce government accountability office bolster health research arpa h

Play Episode Listen Later Jan 23, 2025 9:35

The Advanced Research Projects Agency - Health, known as ARPA-H, is tiny at only 118 employees. Its personnel needs are highly specific, though. ARPA-H has used a variety of strategies to get the people it needs. The Government Accountability Office finds, the agency needs a more organized approach. More now from the GAO's director of science, technology assessment and analytics, Candice Wright. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How a leading health research agency can bolster its workforce

agency workforce government accountability office bolster health research arpa h

Play Episode Listen Later Jan 23, 2025 10:20

The Advanced Research Projects Agency - Health, known as ARPA-H, is tiny at only 118 employees. Its personnel needs are highly specific, though. ARPA-H has used a variety of strategies to get the people it needs. The Government Accountability Office finds, the agency needs a more organized approach. More now from the GAO's director of science, technology assessment and analytics, Candice Wright. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Building the Infrastructure for Longevity Medicine: ARPA-H's PROSPR Program (Dr. Andrew Brack, Program Manager)

Translating Aging

Play Episode Listen Later Jan 9, 2025 40:29

Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human healthspan. In this wide-ranging conversation, Chris and Andrew explore how PROSPR plans to accelerate the development of therapies that target aging itself by building the regulatory and scientific infrastructure needed to measure and improve health during aging. They discuss PROSPR's innovative approaches to in-home data collection, biomarker development, and clinical trial design that could compress decades-long studies into just three years.The Finer Details:The mission and structure of ARPA-H as a catalyst for healthcare innovationHow PROSPR aims to build "train tracks" for the longevity therapeutics industryThe program's novel approach to measuring health through intrinsic capacityStrategies for compressing clinical trials from decades to yearsThe economic impact of extending healthspan by just one yearPlans for first- and second-generation therapeutics targeting agingThe role of in-home health monitoring in future clinical trialsQuote: "We have this moral imperative to close the gap between the length that we are living and the number of years that we're living in good health."Links:PROSPR websiteProposers' Day registration

medicine infrastructure longevity program managers brack advanced research projects agency arpa h

President Biden is set to issue AI national security memo

The Daily Scoop Podcast

Play Episode Listen Later Oct 24, 2024 2:59

President Joe Biden will issue a memo and framework on the use of AI in the context of national security Thursday, with the aim of providing steps for U.S. leadership and guardrails for governance of the technology. Under the memo, agencies will be directed to access “the most powerful AI systems and put them to use,” senior administration officials who briefed reporters on the memo ahead of its release said. The memo will also bolster the role of the AI Safety Institute and provide direction to agencies for AI use for national security. The Advanced Research Projects Agency for Health, known as ARPA-H, is seeking information about how autonomous artificial intelligence systems, known as agentic AI, might be used in the health care space. A recent request for information posted by the Department of Health and Human Services agency specifically asks for information on implementations of agentic AI, how multiple agentic AI systems work together, scalability, risks, and how autonomy is decided, among other things. The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast on on Apple Podcasts, Soundcloud, Spotify and YouTube.

spotify health ai washington joe biden soundcloud human services national security memo advanced research projects agency arpa h

Two new HHS programs to help with complicated health challenges

programs complicated two new health challenges arpa h

Play Episode Listen Later Oct 23, 2024 10:56

The Advanced Research Projects Agency-Health, ARPA-H, has launched two new programs aimed at the kinds of tough problems the agency specializes in. One deals with artificial intelligence models to predict drug safety. The other with computation systems needed to design vaccines. Details now from ARPA-H program manager Dr. Andy Kilianskhttps://arpa-h.gov/news-and-events/arpa-h-launches-program-develop-predictive-drug-safety-and-efficacy-modelshttps://arpa-h.gov/news-and-events/arpa-h-announces-awards-develop-computational-platform-multi-virus-vaccine-design Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Two new HHS programs to help with complicated health challenges

programs complicated two new health challenges arpa h

Play Episode Listen Later Oct 23, 2024 11:41

The Advanced Research Projects Agency-Health, ARPA-H, has launched two new programs aimed at the kinds of tough problems the agency specializes in. One deals with artificial intelligence models to predict drug safety. The other with computation systems needed to design vaccines. Details now from ARPA-H program manager Dr. Andy Kiliansk https://arpa-h.gov/news-and-events/arpa-h-launches-program-develop-predictive-drug-safety-and-efficacy-models https://arpa-h.gov/news-and-events/arpa-h-announces-awards-develop-computational-platform-multi-virus-vaccine-design Learn more about your ad choices. Visit podcastchoices.com/adchoices

CyberCast: New ARPA-H Program Uses Automation to Defend Against Cyber Threats

GovCast

Play Episode Listen Later Oct 15, 2024 20:38

The Advanced Research Projects Agency for Health (ARPA-H) has launched a new program providing health care organizations a rapid and secure cyber solution that will protect their infrastructure from threats and prevent disruptions in patient care. ARPA-H Resilient Systems Program Manager Andrew Carney discusses the Universal Patching Intermediation for Autonomous Defense (UPGRADE) program and how it offers medical facilities protection from ransomware attacks by automatically providing proactive and scalable updates to their IT systems. Carney highlighted another ARPA-H program called the Digital Health Security Initiative (DIGIHEALS) that's addressing vulnerabilities in data security. He also shared details about the agency's collaborative efforts with its defense counterpart, DARPA.

automation defend carney darpa cyber threats advanced research projects agency arpa h cybercast

How HHS aims to keep AI-enabled medical devices working as they should.

health ai artificial aims enabled medical devices advanced research projects agency arpa h

Play Episode Listen Later Sep 17, 2024 10:49

Artificial intelligence has penetrated deeply into the world of medical devices. The DA has approved nearly a thousand AI-enabled medical gadgets. Given that nature of AI, the question must be asked: How to keep these devices working properly overtime. That's a question the Advanced Research Projects Agency for Health seeks to answer. For details, we turn to ARPA-H program manager Berkman Sahiner. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How HHS aims to keep AI-enabled medical devices working as they should.

health ai artificial aims enabled medical devices advanced research projects agency arpa h

Play Episode Listen Later Sep 17, 2024 11:34

Artificial intelligence has penetrated deeply into the world of medical devices. The DA has approved nearly a thousand AI-enabled medical gadgets. Given that nature of AI, the question must be asked: How to keep these devices working properly overtime. That's a question the Advanced Research Projects Agency for Health seeks to answer. For details, we turn to ARPA-H program manager Berkman Sahiner. Learn more about your ad choices. Visit megaphone.fm/adchoices

Moonshots and Bold Bets with Renee Wegrzyn

The Other 80

Play Episode Listen Later Sep 4, 2024 43:13

Government systems often take a lot of flack for their (sometimes) built-in inability to take risks and make big bets. So, what would it take to encourage the government to take those big, risky moonshots? For Health, that's the role of ARPA-H – to fund new ways of improving health by investing in people with big ideas. We sat down with ARPA-H Director Renee Wegrzyn at Aspen Ideas Health to talk about how it's going and what comes next. We discuss:Why ARPA-H is personal for President Biden.How ARPA-H's special authorities – from flexible hiring to novel contracting – are its secret weapons for speed and scale.The critical role of Program Managers – single decision maker driving the vision and execution of each $50-$200 million initiative.Renee says ARPA-H gives her the ability to direct funds into areas that are sometimes left off the list of “must haves” for innovation:“...one of the only top down things I've done as a director is said, ‘Why aren't we funding more in women's health? We don't have any program managers in the pipeline that want to exclusively focus on this'. But I think we all inherently understand that women are underrepresented in almost every aspect of health. So I asked our [Program Managers].. who wants to raise [a] hand and pick a topic that is really either unique to women, or is disproportionately affecting women that we can do a sprint and invest around. And so I got six Program Managers to come up with topics, everything from Women's Health at home, to brain health, to understanding and quantifying pain – and through the Investor Catalyst Hub we have worked with investors to understand what kind of convincing scale do we need to get to for you to be the second investor. And we competed this across the country.”Relevant LinksAbout ARPA-H ARPA-H Health Equity Factsheet The Minor Consult Podcast EpisodeARPA - H TimelineYoutube Conversation with New Yorker writerWhite House FAQ Sheet on ARPA-HAbout Our GuestDr. Renee Wegrzyn is the first director of the Advanced Research Projects Agency for Health (ARPA-H), appointed by President Biden on October 11, 2022. Previously, she was the Vice President of Business Development at Ginkgo Bioworks and Head of Innovation at Concentric by Ginkgo, where she focused on synthetic biology for combating infectious diseases like COVID-19.Wegrzyn has experience with DARPA and IARPA, the models for ARPA-H. At DARPA, she used synthetic biology and gene editing to enhance biosecurity and the bioeconomy, managing programs like Living Foundries, Safe Genes, PREPARE, and DIGET. She received the Superior Public Service Medal for her DARPA work. Her career includes leading biosecurity and gene therapy teams in private industry, developing immunoassays and diagnostics. Wegrzyn has served on various scientific advisory boards, including those for the National Academies and the Air Force Research Labs. She holds a Ph.D. and a bachelor's degree in applied biology from the Georgia Institute of Technology and completed...

Pharma and Biotech Daily: Navigating Challenges and Innovations in the Industry

Pharma and BioTech Daily

Play Episode Listen Later Sep 4, 2024 4:05

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viral vector manufacturers are facing challenges such as high production expenses, low titers, empty capsids, and limited scalability when producing cell and gene therapies. To overcome these challenges, they are turning to next generation production processes to create a cost-effective and robust AAV manufacturing process. This new approach aims to produce higher titers and full capsids, increase efficiencies resulting from high yields, and drive down the cost per dose. By implementing these strategies, manufacturers can improve the productivity of AAV production and bring promising treatments to the market more effectively.Embecta received FDA approval for its insulin patch pump, featuring a larger insulin reservoir based on feedback from people with type 2 diabetes. Meanwhile, Illumina avoided a fine for its acquisition of Grail in a European court victory. The ARPA-H program will focus on AI degradation in medical tools, while a pathology group is suing to block an FDA lab test rule. Additionally, Medtronic's chief medical officer of acute care and monitoring has departed for a new role.The text discusses various updates in the biopharma industry as of September 3, 2024. It covers topics such as the next challenger to Prevner, advancements in AI drug discovery, concerns over suicide risk of obesity drugs, Recursion's lead drug safety, Vaxcyte's positive data for a pneumococcal vaccine, Sanofi's mixed results in MS drug trials, and the value of digital insights in pharma success.A new study predicts a healthcare labor shortage by 2028, with certain states and specialties facing acute shortages. The study also reveals disparities in fighting medical bills, as uninsured and less educated patients are less likely to question their bills. The ARPA-H program will focus on addressing AI degradation in medical tools. Other updates include tracking healthcare worker strikes and data breaches. The use of technology is transforming healthcare to combat challenges such as workforce shortages and shifting care utilization patterns.FDA Commissioner Dr. Robert Califf is considering reforms to advisory committees, including potentially scrapping expert voting in some circumstances. Califf believes that the discussions within these committees may be more valuable to the FDA than the final vote outcomes. Eliminating voting could help clarify the role of advisory committees. Other potential reforms being discussed include addressing conflicts of interest.The text discusses the importance of getting the Institutional Review Board (IRB) review right the first time and introduces a checklist of critical questions to ask potential IRB partners to ensure a smoother review process. By asking the right questions and choosing the right IRB, the review process can be more efficient and effective.Novo Nordisk's drug Ozempic will continue to face shortages into the fourth quarter due to supply issues, even as the company tries to expand its indication. Astellas Gene Therapies is closing its biomanufacturing facility in San Francisco, affecting about 100 employees and shifting manufacturing to North Carolina.In a landscape where consumers are willing to switch brands to save money, it is crucial for brands to establish and maintain loyalty among shoppers. By leading with value, moving consumers from awareness to loyalty to advocacy, and creating connection and community, brands can build brand love even in the face of economic pressures.The text discusses how emerging oncology innovations have led to more effective therapies for cancer patients. The increased investment in cancer research has introduced new treatments such as cell and gene therapies, antibody drug conjugates, and checkpoint inhibitors. Despite these advancements, the industry still faces challenges in expanding access and improving outcomes.

ai news challenges san francisco navigating ms european innovation north carolina viral fda eliminating ozempic pharma biotech medtronic grail sanofi novo nordisk irb illumina aav recursion arpa h fda commissioner dr institutional review board irb

Healthier America: ARPA-H and the Return on Investment for the American People with Dr. Renee Wegrzyn

Innovate and Elevate

Play Episode Listen Later Aug 20, 2024 29:24 Transcription Available

In this episode of Innovate and Elevate, Sharon Kedar is joined by Dr. Renee Wegrzyn, the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H), a government agency designed to drive high-impact health innovations. Appointed by President Biden in 2022, Dr. Wegrzyn shares her deep experience in both synthetic biology and biosecurity, drawing from her work at DARPA, IARPA, and Ginkgo Bioworks.The conversation dives into the unique role of government in fostering breakthrough technologies, emphasizing ARPA-H's mission to transform health outcomes. Dr. Wegrzyn explains how ARPA-H takes on ambitious, high-risk projects with the potential to revolutionize healthcare, much like DARPA's past successes in defense technologies, such as the early development of mRNA technology.Dr. Wegrzyn highlights ARPA-H's approach to maximizing the return on investment for American taxpayers by focusing on scalable, impactful solutions that can transition to the private sector. She walks listeners through transformative projects, including NITRO, GLIDE, ADAPT, and POSEIDON. ARPA-H has a unique Program Management structure, which provides hands-on mentorship and support to ARPA-H grantees. Dr. Wegrzyn identifies how the partnership helps innovators address cost, accessibility, and user experience in health innovations. Sharon and Dr. Wegrzyn also discuss the ARPA-H's Sprint for Women's Health and how the funding opportunity addresses critical unmet challenges in the women's health sector. Episode Outline(01:50) How the US Government Drives Innovation (04:01) The Return on Investment to Americans (09:27) ARPA-H Programs and Funding (12:42) How To Work with ARPA-H (15:28) The Audacity to Imagine Success (18:59) Improving Research and the Standard of Care (21:40) Women's Health Innovation (26:45) Beyond Conversation: Embracing Data-Driven Solutions Connect with SharonConnect with Sharon on LinkedIn: Sharon KedarLearn more about Innovate and Elevate innovateandelevatepodcast.comSubscribe to Innovate and Elevate on YouTubeJoin the newsletter to receive the latest episodes in your inbox: Innovate and Elevate NewsletterConnect with Dr. Renee WegrzynFollow Renee on LinkedInLearn more on the ARPA-H websiteAdditional ResourcesSubscribe to the ARPA-H Vitals newsletterFull list of ARPA-H programsThe hidden questions behind the Heilmeir QuestionsThe White House Initiative on Women's Health ResearchThis podcast is produced by the women at

Don Kinzler's fall garden tips; Iconic sunflower; ARPA-H's bold health initiatives

Main Street

Play Episode Listen Later Aug 12, 2024 50:16

Don Kinzler shares fall gardening tips. Dr. Renee Wegrzyn discusses ARPA-H's bold health initiatives on "Conversations on Health Care" and and Chuck Lura explores North Dakota's iconic sunflowers.

health conversations gardens healthcare iconic north dakota initiatives sunflowers fall garden arpa h

Self-healing joints? Perfect surgeries? Your tax $$ could make it happen

Play Episode Listen Later Aug 8, 2024 31:52

The director of the Advanced Research Projects Agency for Health (ARPA-H) knows the eyes of the nation are on her. Renee Wegrzyn, Ph.D., leads the billion-dollar effort charged with leveraging research advances for real-world impact.Wegrzyn talked with hosts Mark Masselli and Margaret Flinter at Aspen Ideas: Health about the agency's initiatives, including a $100 million sprint for women's health and creating tissue-specific delivery of therapies.“How can we pursue some of these breakthroughs — in our case, for health — by empowering the scientists…the program managers…that have these really big ideas that are so risky that the technical sector, the private sector can't address because there's no proof of concept?”She explained the process: Hire program managers with big ideas in health and give them a time frame to find solutions.Wegrzyn said the time limit ensures they bring a sense of urgency to solving problems. In return, participants get resources to focus on technical risks.Many of ARPA-H's missions are cancer-centered, aimed at issues through what-if questions such as: “What if cancer surgeries were one-and-done?” “What if clinical trials evolved in the same way tumors do?”She said, “The investments that we've made in cancer [include] our precision surgical interventions program. Think about reimagining the operating room suites, when a surgeon is looking into a surgical cavity and trying to remove a tumor.” Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

hire self healing make it happen joints surgeries advanced research projects agency arpa h mark masselli margaret flinter

Self-healing joints? Perfect surgeries? Your tax $$ could make it happen

ceo founders google technology microsoft wright advisor rural board members north korean mcmillan key points disparities drex cyberforce arpa h

Play Episode Listen Later Aug 8, 2024 31:52

The director of the Advanced Research Projects Agency for Health (ARPA-H) knows the eyes of the nation are on her. Renee Wegrzyn, Ph.D., leads the billion-dollar effort charged with leveraging research advances for real-world impact. Wegrzyn talked with hosts Mark Masselli and Margaret Flinter at Aspen Ideas: Health about the agency's initiatives, including a $100 million sprint for women's health and creating tissue-specific delivery of therapies. “How can we pursue some of these breakthroughs — in our case, for health — by empowering the scientists…the program managers…that have these really big ideas that are so risky that the technical sector, the private sector can't address because there's no proof of concept?” She explained the process: Hire program managers with big ideas in health and give them a time frame to find solutions. Wegrzyn said the time limit ensures they bring a sense of urgency to solving problems. In return, participants get resources to focus on technical risks. Many of ARPA-H's missions are cancer-centered, aimed at issues through what-if questions such as: “What if cancer surgeries were one-and-done?” “What if clinical trials evolved in the same way tumors do?” She said, “The investments that we've made in cancer [include] our precision surgical interventions program. Think about reimagining the operating room suites, when a surgeon is looking into a surgical cavity and trying to remove a tumor.”

hire self healing make it happen joints surgeries advanced research projects agency arpa h mark masselli margaret flinter

UnHack (the News): Rural Disparities, ARPA-H, and Cyber Force with Wes Wright and Mac McMillan

Today in Health IT

Play Episode Listen Later Aug 5, 2024 21:45 Transcription Available

August 5, 2024: Wes Wright, Chief Healthcare Officer at Ordr, and Mac McMillan, Founder, CEO, Board Member, and Advisor, join Drex for the news. The discussion highlights the persistent disparity in healthcare access between rural and urban areas, questioning whether technology alone can bridge this gap. The conversation also explores the ARPA-H initiative, pondering if new technology development is necessary when existing tools might suffice. The trio reflects on the creation of a dedicated Cyber Force, drawing parallels with military coordination to enhance cybersecurity. Should the government play a more significant role in supporting private sector defenses? They further discuss the indictment of a North Korean cybercriminal, debating the implications of such actions and the broader geopolitical context.Key Points:00:37 Rural Healthcare Challenges02:54 Technology and Socioeconomic Issues05:58 ARPA-H Initiative and Military Healthcare09:17 The Case for a Cyber Force13:54 North Korean Cyber Threats and Final ThoughtsNews articles:Microsoft and Google are helping rural hospitals protect themselves from cyberattacksUS indicts North Korean hacker accused of helping extort US hospitals | CNN PoliticsA Cyber Force Is Not the Only Solution - War on the RocksThis Week Health SubscribeThis Week Health TwitterThis Week Health LinkedinAlex's Lemonade Stand: Foundation for Childhood Cancer Donate

Exploring ARPA-H Innovations: Insights with Craig Gravitz and Jenica Patterson, Ph.D.

BioTalk with Rich Bendis

Play Episode Listen Later Aug 5, 2024 39:12

In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., welcomes guests from ARPA-H: Craig Gravitz, Director of the Project Accelerator Transition Innovation Office (PATIO), and Jenica Patterson, Ph.D., Portfolio Lead at ARPA-H. Together, they provide a comprehensive overview of ARPA-H's mission and innovative programs. Craig Gravitz and Jenica Patterson share their educational and career backgrounds, setting the stage for a discussion about ARPA-H and its various initiatives. They provide insights into how ARPA-H differentiates itself from other agencies like HHS and NIH, while also highlighting their collaborative efforts. Listeners will learn about the Project Accelerator Transition Innovation Office (PATIO) and its crucial role within ARPA-H. Jenica Patterson discusses her portfolio, including key areas and projects, and provides details on the new women's sprint for health initiative and its funding tracks. The conversation highlights examples of ARPA-H investments and milestones achieved, as well as the processes involved in determining future programs and investment priorities. Craig and Jenica also discuss the unique Entrepreneur in Residence (EIR) program and how it supports ARPA-H projects. About Craig Gravitz: Craig Gravitz is designing and implementing the transition and commercial strategy for the Advanced Research Projects Agency for Health (ARPA-H). Prior to joining ARPA-H, Mr. Gravitz launched and ran a research and development program at the Defense Logistics Agency. He is a licensed attorney and has previously serviced as a contracting officer. About Jenica Patterson, Ph.D.: Jenica Patterson, Ph.D is a Portfolio Lead at ARPA-H within the Project Accelerator Transition Innovation Office (PATIO) and leads the Sprint for Women's Health. Formerly Dr. Patterson served as the Director of the Technology Transfer and Transition (T3X) Division in the PATIO office, where she oversaw public-private partnerships for transition and the small business program for ARPA-H. Dr. Patterson received her Ph.D in Neuroscience at the University of Maryland, Baltimore County (UMBC) and served as a Science and Technical Advisor at the Defense Advance Research Project Agency, and a Program Director at NIH prior to joining ARPA-H. Tune in to BioTalk for an informative discussion with Craig Gravitz and Jenica Patterson as we explore the innovative work of ARPA-H and its impact on health research and development.

EP. 636 – CrowdStrike, Palantir, Carbyne, and ARPA-H.

American Education FM

Play Episode Listen Later Jul 22, 2024 72:19

I discuss Crowdstrike and their history, along with the Q drops that describe their intentions and what the shutdown may have really been about; I discuss the company Palantir and the work of Whitney Webb and her dig on their connections to mass surveillance and pre-crime; I also dive briefly into their sister companies Carbyne and ARPA-H and how they are designed to surveil and socially engineer the masses to ultimately kill us. Crowdstrike: https://archive.4plebs.org/pol/thread/474868046 Palantir https://theamericanclassroom.substack.com/p/palantir-mass-surveillance-and-pre

crowdstrike palantir whitney webb arpa h carbyne

The Possibilities of Vision Restoration

On Tech & Vision With Dr. Cal Roberts

Play Episode Listen Later Jul 12, 2024 44:10

This podcast is about big ideas on how technology is making life better for people with vision loss. For hundreds of years, health professionals have dreamed of restoring vision for people who are blind or visually impaired. However, doing so, either through transplanting a functioning eye or using technological aids, is an incredibly complex challenge. In fact, many considered it impossible. But thanks to cutting-edge research and programs, the ability to restore vision is getting closer than ever. As a first for this podcast, this episode features an interview with Dr. Cal Roberts himself! Adapting audio from an interview on The Doctors Podcast, Dr. Cal describes his work as a program manager for a project on eye transplantation called Transplantation of Human Eye Allographs (THEA). Funded by a government initiative called ARPA-H, THEA is bringing some of the country's finest minds together to tackle the complexities of connecting a person's brain to an eye from a human donor. This episode also features an interview with Dr. Daniel Palanker of Stanford University. Dr. Palanker is working on technology that can artificially restore sight through prosthetic replacement of photoreceptors. Having proved successful in animals, Dr. Palanker and his team are working hard to translate it to humans. And if that can happen, then something once considered impossible could finally be accomplished! The Big Takeaways The Challenges of Eye Transplants: Although eyeball transplants have been done, they've only been cosmetic. So far, nobody has been able to successfully connect a donor eyeball to a recipient's brain. Dr. Roberts's work with THEA is bringing together multiple teams to tackle the challenges associated with a whole eyeball transplant, from connecting nerves and muscles to ensuring the organ isn't rejected, and much more. “Artificial” Vision Restoration: Dr. Palanker is working to replace the functions of photoreceptors through technological means. His photovoltaic array is placed underneath the retina and can convert light into an electrical current that activates the cells that send visual information to the brain. While it doesn't completely restore sight for people with Age-Related Macular Degeneration, this technology shows incredible promise. Decoding “Brain Language”: For both Dr. Roberts and Dr. Palanker, one of the biggest challenges with vision restoration is understanding how the eye and brain communicate. Dr. Roberts likens it to Morse Code — the eye speaks to the brain in “dots and dashes,” which the brain then converts into vision. Right now, the language is still foreign to us, but we're closer than ever to decoding it. The Evolution of the Brain-Machine Interface: Dr. Palanker imagines incredible possibilities in the interaction between the brain and technology. If we can find a way to truly translate the brain's signals into information, Dr. Palanker envisions the possibility of direct brain-to-brain communication without verbalization. In a way, this could make people telepathic, able to understand and digest vast amounts of information in an instant. Tweetables: So ideally in medicine, at least the ideal therapy is the restoration of full functionality. If we can grow back photoreceptors and make them reconnect to bipolar cells, undo all the rewiring that right now underwent during degeneration, and restore the full extent of vision, that would be the ideal outcome. — Dr. Daniel Palanker, Professor of Ophthalmology, Stanford University We can think about other aspects of brain-machine interface, which takes you maybe into the realm of capabilities that humans never had. If you enable artificial senses or enable brain-to-brain connectivity so you can communicate without verbalization that would open completely new capabilities that humanity never had. — Dr. Palanker Forty-two years after the implantation of the first mechanical heart, there's not a single person in the world walking around with a mechanical heart. All that work, all that research, and all that effort to come up with mechanical heart transplants are still state-of-the-art. And so, while I believe that there is a role for a bionic eye or mechanical eye, what I really believe is that everything that we learn from doing an eye transplant will just make it better and easier when we do eventually come up with a bionic or a mechanical eye. — Dr. Calvin Roberts, ARPA-H Health Science Futures Program Manager (President and CEO of Lighthouse Guild and Host of On Tech & Vision!) Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss. Pertinent Links Lighthouse Guild THEA Program Prima System People's Choice Podcast Awards We appreciate your support for our show — and now, we need your help nominating the On Tech & Vision podcast for the People's Choice Podcast Awards! We are participating in these awards so we can showcase On Tech & Vision to a broader audience, gain recognition within the industry, and, most importantly, help spread the message about Lighthouse Guild and the role that technology is playing in tearing down barriers for people who are blind or visually impaired. To help us nominate On Tech & Vision, please go online to www.podcastawards.com, where you can register to vote for On Tech & Vision in both the Technology and Peoples' Choice Categories. Voting is open until July 31st. Once again, your support is greatly appreciated!

ceo technology vision professor evolution restoration voting stanford university roberts adapting possibilities peoples funded ophthalmology transplantation morse code choice podcast awards arpa h palanker calvin roberts

Innovative Health Care by Design: Bon Ku, MD, MPP | Advanced Research Projects Agency for Health (ARPA-H)

The Next Big Thing in Health

Play Episode Listen Later Jul 2, 2024 15:40

Host Robert Traynham is joined by Dr. Bon Ku of the Advanced Research Projects Agency for Health (ARPA-H), a new federal agency aimed at pioneering ambitious health care initiatives. Dr. Ku will talk about the PARADIGM program, rural health care, and the concept of health care design.

design healthcare innovative paradigm ku advanced research projects agency arpa h

Episode 48: Dr. Renee Wegrzyn on ARPA-H

NatSec Tech

Play Episode Listen Later Jun 19, 2024 27:01

Director of ARPA-H, Dr. Renee Wegrzyn, joins host Jeanne Meserve for a live conversation to discuss the agency's role in investing in new and critical technologies at SCSP's AI Expo. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit scsp222.substack.com

director arpa h

Reid Hoffman, Renee Wegrzyn & Regina Barzilay on the AI revolution and its impact on health-care

Washington Post Live

Play Episode Listen Later Jun 14, 2024 0:06

Reid Hoffman, co-Founder of LinkedIn and Inflection AI discusses the possibilities and risks that artificial intelligence will pose over the next decade and why he believes everyone will have an AI digital agent in the future. Then, ARPA-H director, Renee Wegrzyn and MIT School of Engineering Professor of AI and Health discuss how AI is changing the health-care landscape and what the industry can do right now to implement the technology into its infrastructure. Conversation recorded on June 13, 2024 at The Futurist: The Age of AI summit.

founders health ai conversations healthcare ai revolution reid hoffman inflection ai arpa h

CCT 145: Practice CISSP Questions - Data Classification and Protection for the Exam (Domain 2.1.1)

CISSP Cyber Training Podcast - CISSP Training Program

Play Episode Listen Later May 30, 2024 25:40 Transcription Available

Ever wondered how to navigate the complexities of data classification within your organization? Get ready to sharpen your cybersecurity skills and elevate your knowledge as we dissect CISSP Question Thursday, focusing on domain 2.1.1. This week, we also bring you an intriguing piece of news about ARPA-H, a groundbreaking new agency inspired by DARPA but aimed at revolutionizing healthcare through cutting-edge technology. With a starting fund of $50 million, ARPA-H is set to tackle critical issues like ransomware in the healthcare sector, presenting immense opportunities for those in the cybersecurity field.We go beyond the basics as we cover crucial aspects of data classification and security protocols across diverse organizational contexts. Learn how to classify different types of data, from marketing campaign materials to sensitive patient information, and understand why encryption is essential for protecting data at rest. We also discuss the limitations of Data Loss Prevention (DLP) solutions and offer key security considerations for managing user geolocation data in mobile apps. This episode is a must-listen for anyone preparing for the CISSP exam or looking to enhance their cybersecurity expertise.Gain access to 30 FREE CISSP Exam Questions each and every month by going to FreeCISSPQuestions.com and sign-up to join the team for Free. Gain access to 60 FREE CISSP Practice Questions each and every month for the next 6 months by going to FreeCISSPQuestions.com and sign-up to join the team for Free. That is 360 FREE questions to help you study and pass the CISSP Certification. Join Today!

practice data exam domain classification darpa cissp arpa h

Following the Money in Women's Health - From Biden's Executive Order, ARPA-H Sprint, to Oprah is Women's Health Finally Going to Get the Attention it Needs Deserves?

Digital Health Talks - Changemakers Focused on Fixing Healthcare

Play Episode Listen Later May 23, 2024 36:22

In this thought-provoking session, we will delve into the recent surge of attention and investment in women's health. From President Biden's groundbreaking Executive Order to the ambitious ARPA-H Sprint, and even celebrity advocacy, the landscape of women's health is undergoing a significant transformation. Join us for an insightful discussion as we navigate the evolving landscape of women's health. We explore how health IT leaders can capitalize on this unprecedented attention to drive meaningful advancements in care delivery, research, and innovation. Together, we will assess whether women's health is finally receiving the attention and investment it deserves and chart a course for a more equitable and empowering future. As health IT leaders, it is crucial to understand how these developments will impact our strategies, investments, and the overall direction of the industry. We will explore the following key aspects:State of Innovation in Women's HealthFrom Mensus to Menopause Who Pays and Why? Identifying key areas of opportunity for health IT investments, partnerships, and collaborations that align with the current focus on women's health and strategies to optimize resource allocation and maximize impactBiden's Executive Order: Analyzing the implications of the President's directive on women's health and how it will shape policies, funding, and priorities in the healthcare sector.Accelerating innovation through a $100 million ARPA-H women's health sprint- discussing how this initiative could accelerate innovation and drive meaningful change.Assessing the impact of high-profile figures like Oprah in raising awareness and mobilizing resources for women's health causes, and exploring how health IT leaders can leverage this momentum to drive positive outcomes. Katie McMillan, CEO, Well Made Health, LLCMegan Antonelli, Chief Executive, Officer HealthIMPACT

Newsday: Mandates, Regulations, and Other Ways to Protect Your Data with David Ting

Today in Health IT

Play Episode Listen Later Apr 8, 2024 25:31 Transcription Available

April 8, 2024: David Ting, Founder and CTO at Tausight joins Drex DeFord, President, 229 Risk & Security at This Week Health for the news. As we delve into the conversation, Ting shares his insights on the challenges and opportunities presented by the current state of cybersecurity in healthcare, particularly in light of recent high-profile cyber events. How will increased regulations and mandates impact healthcare organizations, and is there a balance to be struck between compliance and genuine security? Ting also explores the hyperconnected nature of healthcare and the vulnerabilities it introduces. Could the solution lie in not just more regulations but in providing healthcare organizations with the necessary incentives and financial assistance to bolster their cybersecurity measures? Furthermore, we touch upon the potential of AI in revolutionizing healthcare cybersecurity, as highlighted by the partnership between ARPA H and DARPA.Key Points:Impact of Increased RegulationsFinancial Assistance and IncentivesSecuring Pediatric Health DataPartnership Between ARPA H and DARPANews articles:Processing Mismanagement: Responding to Change Healthcare's Meltdown - 4sight HealthDear Colleague Letter2 Minute Drill: Budget Dust and Cyber Urgency: A Call for Stronger Hospital SecurityRansomware attack on Change Healthcare pegged as "most significant" in sector historyThis Week Health SubscribeThis Week Health TwitterThis Week Health LinkedinAlex's Lemonade Stand: Foundation for Childhood Cancer Donate

founders president ai data risk security protect cto meltdown regulations mandates ting darpa newsday change healthcare arpa h

Dr. Darshak Sanghavi, MD - Program Manager, Resilient Systems Mission Office, Advanced Research Projects Agency for Health (ARPA-H) - Radically Different Approaches Towards Preventative Healthcare

StartUp Health NOW Podcast

Play Episode Listen Later Mar 28, 2024 48:12

Dr. Darshak Sanghavi, MD ( https://arpa-h.gov/about/people/darshak-sanghavi ) is Program Manager, Resilient Systems Mission Office, at ARPA-H where he heads up the HEalthcare Rewards to Achieve Improved OutcomES ( HEROES - https://arpa-h.gov/research-and-funding/programs/heroes ) program which aims to trial and validate radically different approaches to creating preventative care incentives in the health market, one example being offering direct payments to individual “health accelerators” – such as non-profits or care consortiums – that successfully implement preventative care campaigns that improve the rates for specific health harms in an entire geographic population. Dr. Sanghavi joined ARPA-H in May 2023 from Babylon – a digital-first, end-to-end health care provider serving more than 24 million people across the globe. As chief medical officer, he was responsible for overseeing the company's international operations as well as leading its wider mission to help bring affordable and accessible health care to everyone worldwide. Previously, Dr. Sanghavi worked as national chief medical officer for UnitedHealthcare and OptumLabs, as a group director at the Centers for Medicare & Medicaid Services Innovation Center during the Obama Administration, as managing director of the Engelberg Center for Health Care Reform at the Brookings Institute, and as a pediatrician for the U.S. Indian Health Service. Dr. Sanghavi has a doctorate in medicine from Johns Hopkins University and specializes in pediatric cardiology after training at Boston Children's Hospital. Dr. Sanghavi is also a best-selling author, with his book "A Map of the Child: A Pediatrician's Tour of the Body", available at all major book sellers, and a regular contributor to the New York Times, Boston Globe, and Washington Post. Support the show

Inside the Health Moonshot Impact Board: A Conversation with Margaret Laws and Shirley Bergin

Play Episode Listen Later Mar 22, 2024

This week on StartUp Health NOW, we have again handed over the microphones to two members of our Health Moonshot Impact Board and having them interview each other. At one end of the table we've got Margaret Laws, CEO & President of HopeLab, former Director of Innovations for the Underserved at CHCF, and Founder of the CHCF Health Innovation Fund, and at the other end of the interview table is Shirley Bergin, Senior Advisor at ARPA-H, Former CMO/COO of TEDMED, and Advisor to Ellipsis Health and Cure. The goal of the conversation was simply to hear about the latest projects and passions of two of the most influential and interesting people in health innovation. In the interview, which took place in person at the Lake Nona Impact Forum in Florida, we cover a range of topics, from youth mental health, to the role of AI in diagnostics, to education to address global gaps in the healthcare workforce. Margaret Laws and Shirley Bergin are thought leaders in health innovation, but they're also deeply involved in directing funds towards promising programs, so it will be interesting to see how their curiosities and passions as played out here will lead to concrete moves in the future. Enjoy the conversation. Innovating in Alzheimer's disease? Learn how you can join our new Alzheimer's Moonshot. Passionate about Type 1 diabetes? Learn how you can get one of the last spots in our T1D Moonshot. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Innovators: Health Transformer University fuels your health moonshot Funders: Become a Health Moonshot Champion

Health Horizons: President Biden's Bold Move for Women's Health and Research

AURN News

Play Episode Listen Later Mar 18, 2024 1:45

President Biden has announced a comprehensive initiative, including a new executive order aimed at revolutionizing women's health research and innovation across America. Rooted in his State of the Union vision, Biden has proposed a transformative $12 billion investment to establish a fund for Women's Health Research at NIH. This initiative, the first White House initiative on women's health research, seeks to fundamentally alter the landscape of women's health research in the U.S. and ensure comprehensive integration and prioritization within the federal research agenda. It encompasses a broad spectrum of actions, including a $200 million NIH investment for the 2025 fiscal year and the launch of ARPA-H's Sprint for Women's Health with a $100 million commitment. The initiative's directives include enhancing research across various stages of women's lives, particularly focusing on midlife health challenges and leveraging AI in health research advancements. Learn more about your ad choices. Visit megaphone.fm/adchoices

america women health ai joe biden white house state of the union rooted sprint nih horizons health research arpa h health and research

Dr. Calvin Roberts, MD - Program Manager, Transplantation of Human Eye Allografts (THEA), Advanced Research Projects Agency for Health (ARPA-H) - Transplanting Whole Human Eyes To Restore Vision In Patients Who Are Blind Or Visually Impaired

health government innovation risks national institutes arpa health it advanced research projects agency arpa h healthcast

Play Episode Listen Later Mar 8, 2024 36:56

Dr. Calvin Roberts, M.D. is Program Manager at the Advanced Research Projects Agency for Health (ARPA-H) where manages for the Transplantation of Human Eye Allografts ( THEA - https://arpa-h.gov/research-and-funding/programs/thea ) program, which aims to transplant whole human eyes to restore vision in patients who are blind or visually impaired by reconnecting the nerves, muscles and blood vessels of whole donor eyes to the brain. Dr. Roberts joined ARPA-H in September 2023 from Lighthouse Guild International, where is the president and chief executive officer. Lighthouse Guild is a not-for-profit organization that provides programs and services to people who are blind or visually impaired. Previously, Dr. Roberts was the chief medical officer for the global eye care company Bausch + Lomb. For the past 40 years, Roberts has also served as a clinical professor of ophthalmology at Weill Cornell Medical Center. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries, as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and post-operative cystoid macular edema. Dr. Roberts also hosts the podcast series “On Tech and Vision” ( https://lighthouseguild.org/technology/on-tech-and-vision-podcast/ ) – where innovators discuss how rapidly evolving assistive technology creates equity among those who are visually impaired. Dr. Roberts received his medical degree from Columbia University, completed an internship and ophthalmology residency at New York Presbyterian Hospital, and conducted cornea fellowships at Massachusetts Eye and Infirmary and the Schepens Eye Institute. Support the show

Lessons from Brian Anderson, Chief Digital Health Physician MITRE and Co-Founder of CHAI, on building trustworthy healthcare AI that serve all of us

Pear Healthcare Playbook

Play Episode Listen Later Feb 28, 2024 51:54

This week, we're super excited to chat with Brian Anderson, co-founder of CHAI, Coalition for Health AI, and Chief Digital Health Physician at MITRE. CHAI is a community of academic health systems, organizations, and expert practitioners of artificial intelligence and data science. Brian leads research and development efforts across major strategic initiatives in digital health, partnering with the US government and private sector companies. Prior to joining MITRE, Anderson led the Informatics and Network Medicine Division at athenahealth, where he launched a new model of clinical decision support leveraging artificial intelligence. He has also served on several national health information technology committees in partnership with the Office of the National Coordinator (ONC). On top of all that, Brian is also a Harvard Medical School Associate Professor of Biomedical Informatics and senior advisor for ARPA-H in Clinical Trial Innovation. Anderson completed his clinical training at Massachusetts General Hospital and completed his B.A. and M.D. degrees at Harvard College and Harvard Medical School. In this episode, we talk about Brian's career journey from clinical practice to digital health, CHAI's efforts to establish AI process standards for healthcare, the concept of a federated network of assurance labs, and advice for the health AI innovation community.

Live from Hawaiian Eye 2024

Eyeluminaries

Play Episode Listen Later Feb 23, 2024 48:47

Quick episode summary John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more. Welcome to the Eyeluminaries podcast :00 Review of episode 20 1:16 Intro of Eric D. Donnenfeld, MD 2:06 Understanding the role of private equity: where does it stand and where is it going? 4:22 Do you see a relief in interest rates and the pace picking up for private equity in the years ahead? 7:19 What are the technologies that you are most excited about? 8:17 What are the things to watch out for? 11:08 Do you have an interesting James Worthy story? 13:34 Intro of Calvin C. Roberts, MD 15:21 Transplanting eyes and Advanced Research Project Agency for Health (ARPA-H) 15:48 How does a chief medical officer work within a company? 18:56 How is what ARPA-H doing different than simply transplanting an eye? 20:42 Intro of Mark L. Baum 26:06 What does the rebranding of the company mean? 27:00 Pharmaceutical names: VEVYE 28:22 How will you market VEVYE in the US? 29:48 Fortisite 31:59 What is the future of the company? 32:47 What do you think of Dr. Wiley Chambers' retirement? 34:09 Intro of Jeannette Bankes 36:51 Describe your last five years in the ophthalmic space: the good, the bad, the ugly 39:16 · If you could change anything in the ophthalmic industry, what would it be? 42:53 · How excited are you about robotics? 44:06 · Tell us about your promotion 44:52 · How can we develop a more diverse leadership in ophthalmology? 45:31 Preview of episode 22 48:01 Feedback, questions and guest suggestions at eyeluminaries@healio.com 48:18 Jeannette Bankes is the president and general manager of global surgical franchises for Alcon. Mark L. Baum is the founder, chairman of the board and chief executive officer of Harrow. Eric D. Donnenfeld, MD, is a cornea, laser cataract and refractive surgeon for OCLI Vision. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Calvin C. Roberts, MD, is a program manager for health science futures at ARPA-H. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Bankes is the president and general manager of global surgical franchises for Alcon. Baum is the founder, chairman of the board and chief executive officer of Harrow. Donnenfeld reports consulting widely across the ophthalmic industry with relevant disclosures in this episode as a consultant with Alcon, Bausch + Lomb, LensGen, Ocular Therapeutix and Omeros. Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Thompson is the director of refractive surgery at Vance Thompson Vision. Roberts is program manager for health science futures at ARPA-H.

daily304 - Episode 02.02.2024

daily304's podcast

Play Episode Listen Later Feb 2, 2024 3:17

Welcome to the daily304 – your window into Wonderful, Almost Heaven, West Virginia.  Today is Friday. Feb. 2 Looking for a good-paying and rewarding job? WV corrections facilities are hiring. Two WV chefs are semifinalists for the prestigious James Beard award. And WVU enters a new research partnership that may spark health innovation…on today's daily304. #1 – From JOBCASE – Explore a stable and rewarding career with the West Virginia Division of Corrections and Rehabilitation. As a correctional officer, you'll play a pivotal role in ensuring public safety, upholding public trust and contributing to a higher purpose. You'll be making a real impact on your community. Higher salaries await you, starting at a minimum of $40,000 annually plus a retention bonus after one year and further salary increases after two years. You'll also receive a great benefits package and paid leave. Additional perks include paid training and plenty of advancement opportunities. What are you waiting for? Visit www.jobcase.com/ru/West-Virginia to find out who's hiring! Read more: https://www.jobcase.com/articles/wv-dcr #2 – From WCHS-TV – Two chefs from West Virginia have been recognized for culinary excellence with James Beard Award nominations. Chef Paul Smith, of 1010 Bridge in Charleston, has been nominated for best chef of the southeast while Scott MacGregor, from Snowshoe's Appalachian Kitchen, joins the semifinalist list. “It's a huge deal,” said Smith, who was one of five finalists last year. “I wouldn't say it's a dream come true because it's beyond our wildest dreams. This is the Academy Awards for chefs, so just to be nominated you are an Academy Award-winning chef basically." “It was shocking. It was definitely exciting,” MacGregor said. “It was an honor for me to think that I'm in there with people from huge food cities, like Memphis, Nashville, Charleston, South Carolina and all of these places that are kind these up-and-running food cities. I'm here in the middle of the mountains.” Finalists will be announced in March. Read more: https://wchstv.com/news/local/two-wva-chefs-nominated-for-coveted-james-beard-awards-appalachian-kitchen-scott-macgregor-1010-bridge-paul-smith-snowshoe-charleston-culinary-west-virginia #3 – From WVU TODAY – West Virginia University has been tapped to help accelerate commercialization of medical innovations by collaborating with a nationwide network within the National Institutes of Health. WVU is one of just 127 entities to be named a spokesmember or partner for the Investor Catalyst Hub, a regional hub of the Advanced Research Projects Agency for Health. The University is the only member from West Virginia. ARPA-H's overarching mission is to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions and resilient systems. As a member of the hub, WVU will have access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. “We will be able to tap into a wealth of knowledge and expertise that is represented through the spokes and are excited for the possibilities that will emerge from the ARPA-H partnerships,” said Erienne Olesh, executive director of the Office of Student and Faculty Innovation in the WVU Research Office. Read more: https://wvutoday.wvu.edu/stories/2024/01/29/wvu-selected-to-partner-with-federal-research-entity-to-spark-health-innovation Find these stories and more at wv.gov/daily304. The daily304 curated news and information is brought to you by the West Virginia Department of Commerce: Sharing the wealth, beauty and opportunity in West Virginia with the world. Follow the daily304 on Facebook, Twitter and Instagram @daily304. Or find us online at wv.gov and just click the daily304 logo. That's all for now. Take care. Be safe. Get outside and enjoy all the opportunity West Virginia has to offer.

ARPA-H CIO: Risks are Key to Health IT Innovation

HealthCast

Play Episode Listen Later Jan 18, 2024 21:10

Government is typically not one to take risks, but Advanced Research Projects Agency for Health (ARPA-H) CIO Nikolaos Ipiotis said failing and learning are key parts to tech and health innovation. The agency, the newest one within the National Institutes of Health, aims to transform and innovate in health IT, medicine and other lanes of research that aren't easily available through traditional approaches. Ipiotis, who joined the agency in December 2023, said in his first podcast interview that taking risks, "controlled failure" and collaboration are all keys to his IT strategy. He discusses what lies ahead for data strategy as the agency begins to collaborate with industry and set in motion major initiatives for the health community.

What's a medical innovation federal agency doing in Dallas?

Texas Wants to Know

Play Episode Listen Later Dec 28, 2023 14:40

Texas is a large state with a huge population to take care of. With recent moves to provide better healthcare, Texas is said to be the leading state for advancing healthcare and medical education. Recently, ARPA-H, a medical innovation federal agency, has declared Dallas as one of its three national hub spaces for its medical breakthroughs in science and medicine. So, Texas wants to know, what is ARPA-H and what the hub here means for our state and Texans?

texas health business medicine lifestyle medical agency texans dfw local news federal agencies medical innovation arpa h

Dr Joseph Ladapo

Naturally Inspired Radio - Health. Freedom. News.

Play Episode Listen Later Dec 13, 2023 52:15

Contact Me Here - ❤️ https://bit.ly/m/TammyCuthbertGarcia ❤️ Today on Naturally Inspired Radio lifestyle activities, Dr Joseph Ladapo sends letter to FDA and CDC, pharmacies giant paid 25.8 million dollars to obesity specialists to sell weight loss drugs, anti human cult is after a cure for death, ARPA-H supported by the Biden administration, arthritis solutions, leaky gut, allergies, MSM, healing properties of laughter Tune In to Naturally Inspired Radio Live… Mon-Thu, 3pm (MDT) on 1360am KHNC in Colorado, at https://bit.ly/naturallyinspiredradio Text in your comments/questions to 877-536-1360 and enter to win our weekly giveaway Please Like

New HHS research agency ‘fully embracing' generative AI

health ai research embracing agency national institutes launched generative advanced research projects agency arpa h

Play Episode Listen Later Dec 4, 2023 9:20

The Advanced Research Projects Agency for Health is embracing generative artificial intelligence as part of its internal operations, while also considering how the technology could be used across the broader health ecosystem.Launched in March 2022, ARPA-H is an independent agency within the National Institutes of Health. The organization is modeled after the Defense Advanced Research Projects Agency, with the goal of supporting “transformative research to drive biomedical and health breakthroughs.”Susan Monarez, deputy director at ARPA-H, said officials are already using generative AI technologies to help the new research organization “get our houses in order.” She said the agency processes large volumes of data ranging from personnel information to contracting data to information from partner agencies that help ARPA-H shape its programs. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

New HHS research agency ‘fully embracing' generative AI

health ai research embracing agency national institutes launched generative advanced research projects agency arpa h

Play Episode Listen Later Dec 4, 2023 10:05

The Advanced Research Projects Agency for Health is embracing generative artificial intelligence as part of its internal operations, while also considering how the technology could be used across the broader health ecosystem. Launched in March 2022, ARPA-H is an independent agency within the National Institutes of Health. The organization is modeled after the Defense Advanced Research Projects Agency, with the goal of supporting “transformative research to drive biomedical and health breakthroughs.” Susan Monarez, deputy director at ARPA-H, said officials are already using generative AI technologies to help the new research organization “get our houses in order.” She said the agency processes large volumes of data ranging from personnel information to contracting data to information from partner agencies that help ARPA-H shape its programs. Learn more about your ad choices. Visit megaphone.fm/adchoices

108 | How Artificial Intelligence Can Advance Health Equity

On the Evidence

Play Episode Listen Later Nov 29, 2023 58:17

In September 2023, Mathematica and Congressman Don Beyer's office hosted an event on Capitol Hill to discuss artificial intelligence (AI) and its implications for health equity. This episode of On the Evidence features audio from the September event, anchored by Victoria Knight, a health care policy reporter for Axios, who interviewed Congressman Beyer and moderated a subsequent panel with Ellie Graeden, Jen Roberts, Ngan MacDonald, and Deliya Wesley. • Beyer represents the 8th Congressional District of Virginia and is a vice chair of both the bipartisan Congressional AI Caucus and an AI working group recently formed by the New Democrat Coalition. • Graeden is a professor at the Georgetown University Center for Global Health Science and Security. • Roberts is a director of resilient systems at the Advanced Research Projects Agency for Health, also known as ARPA-H. • MacDonald is the chief of data operations for the Institute for AI in Medicine at Northwestern University. • Wesley is a senior director of health equity at Mathematica. Learn more about how Mathematica's experts harness vast data, advanced analytics, and deep health care policy experience to help organizations make sense of real-world data in a way that enables exploration and innovation: https://mathematica.org/sp/data-analytics/real-world-data Find a transcript of the episode at mathematica.org/blogs/how-artificial-intelligence-can-advance-health-equity

health ai medicine institute security artificial intelligence roberts advance capitol hill northwestern university macdonald congressional districts axios health equity beyer mathematica georgetown university center advanced research projects agency arpa h new democrat coalition global health science jen roberts

HHS launches its promised health innovation network

director health launches promised anchoring health innovation innovation network advanced research projects agency arpa h

Play Episode Listen Later Nov 8, 2023 12:20

The Advanced Research Projects Agency for Health has proceeded with its promised network of health innovation sites. Anchoring the network are three regional hubs also planned at the inception of ARPA-H. For what they hope for the network, Federal Drive Host Tom Temin talked with the Director of the agency's Project Accelerator Transition Innovation office, Craig Gravitz. Learn more about your ad choices. Visit megaphone.fm/adchoices

HHS launches its promised health innovation network

director health launches promised anchoring health innovation innovation network advanced research projects agency arpa h

Play Episode Listen Later Nov 8, 2023 12:05

The Advanced Research Projects Agency for Health has proceeded with its promised network of health innovation sites. Anchoring the network are three regional hubs also planned at the inception of ARPA-H. For what they hope for the network, Federal Drive Host Tom Temin talked with the Director of the agency's Project Accelerator Transition Innovation office, Craig Gravitz. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Season 4 Episode 21 - This NIH Center's Plan Tackles Emerging Tech, Big Data Challenges

HealthCast

Play Episode Listen Later Oct 25, 2023 27:37

Emerging technologies are poised to greatly impact federal agencies. In health care and health research, this is unlocking tremendous opportunity for researchers advancing treatments, diagnostics and more. The National Center for Advancing Translational Sciences's five-year plan outlines how AI and machine learning will address big data and translational barriers. This plan aims to bridge the gap between scientific and operational challenges by improving engagement in the translational space as well as serve as a guide to other agencies when it comes to preparing for future health emergencies like COVID-19. NCAYS Branch Chief of the Office of Policy, Communications and Education Dr. Meredith Temple O'Connor briefs us on this plan plus the expansion of the N3C program comprising COVID clinical data, how AI is shortening the diagnostic odyssey for rare diseases and what's going on with its new partnership with ARPA-H.

covid-19 ai challenges office policy emerging big data national center nih tackles emerging technologies emerging tech education dr arpa h healthcast ncats advancing translational sciences

Drug Fix: US FDA Suffers From Shutdown Threat, Alnylam's CR Letter, ARPA-H Wants FDA Incentives

Pharma Intelligence Podcasts

Play Episode Listen Later Oct 13, 2023 30:03

Pink Sheet reporters and editor discuss the problems that emerged for the US FDA from just the threat of a government shutdown (:38), take-aways on the FDA advisory committee process based on the complete response letter issued for Alnylam's Onpattro (10:25), and incentives that the FDA could offer for ARPA-H projects that reach the application stage (20:16). More On These Topics From The Pink Sheet Shutdown Threat Forced US FDA To Cancel Some Travel: https://pink.citeline.com/PS149003/Shutdown-Threat-Forced-US-FDA-To-Cancel-Some-Travel Alnylam's Complete Response Is Classic Example Of FDA-Advisory Committee Disagreement: https://pink.citeline.com/PS149000/Alnylams-Complete-Response-Is-Classic-Example-Of-FDA-Advisory-Committee-Disagreement US FDA Rejects Onpattro Label Expansion: History Repeats In Reverse?: https://pink.citeline.com/PS149004/US-FDA-Rejects-Onpattro-Label-Expansion-History-Repeats-In-Reverse ARPA-H, US FDA Discuss Incentives For Game-Changing Health Projects: https://pink.citeline.com/PS148944/ARPAH-US-FDA-Discuss-Incentives-For-GameChanging-Health-Projects

letter threats drug fda shutdowns incentives suffers arpa us fda alnylam arpa h pink sheets

In Brief: The New Cancer Moonshot (with Dr. Renee Wegrzyn)

Stay Tuned with Preet

Play Episode Listen Later Oct 2, 2023 24:16

Dr. Renee Wegrzyn is the first director of the Advanced Research Projects Agency for Health, (ARPA-H), a new federal agency with a $2.5 billion budget. Modeled after DARPA, the agency is tasked with taking big risks in biomedical research that seem beyond the reach of the private sector. Dr. Wegrzyn joins Preet to discuss how ARPA-H is promoting innovation, and their goal to “end cancer as we know it.” Stay Tuned is nominated for a Signal Award…and you're in the jury box! Head to cafe.com/signal to vote. Stay Tuned in Brief is presented by CAFE and the Vox Media Podcast Network. Please write to us with your thoughts and questions at letters@cafe.com, or leave a voicemail at 669-247-7338. For analysis of recent legal news, join the CAFE Insider community. Head to cafe.com/insider to join for just $1 for the first month. Learn more about your ad choices. Visit podcastchoices.com/adchoices

head health cafe darpa moonshots modeled preet cancer moonshot signal award advanced research projects agency arpa h vox media podcast network cafe insider

Edwards Lifesciences facing antitrust scrutiny in Europe, NIH chooses Boston as ARPA-H Catalyst Hub

Fast Five Medtech News Podcast

Play Episode Listen Later Sep 28, 2023 10:00

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, September 28, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. QT Medical this week announced it raised $12 million in a Series B funding round. Fast Five hosts Sean Whooley and Danielle Kirsh explain what that technology is and how optimistic executives are feeling after the funding round. BCIs are in the news again this week. This time, Onward announced the first-in-human implant of a stimulator with BCI technology. Whooley details how the technology works with the BCI and what doctors think after the first implant. Boston Scientific won an FDA nod for its intravascular ultrasound system. Hear how the system works and how it assists clinicians, as well as some of the features that help support clinicians. The NIH this week chose Boston as its location for its ARPA-H Catalyst Hub. The Fast Five hosts discuss the details behind this NIH initiative and what organizations will be a part of the hub. Edwards Lifesciences was revealed as the mystery company facing antitrust scrutiny in Europe, first announced last week. Find out what Edwards' response was to the antitrust investigation.

europe facing fda edwards catalyst onward nih life sciences chooses antitrust scrutiny series b fast five bci boston scientific edwards lifesciences arpa h

So far, no FAR: A look inside one agency's unique procurement shop

health unique shop contracts acquisition procurement look inside advanced research projects agency arpa h one agency federal acquisition regulation

Play Episode Listen Later Sep 14, 2023 23:47

Imagine a federal procurement shop where you use every technique, except the Federal Acquisition Regulation. And you don't do grants, either. And you've got congressional backing for your novel approach. That's the case for one of the government's newer agencies, the Advanced Research Projects Agency for Health, known as ARPA-H. For a look on the inside, Federal Drive Host Tom Temin spoke with Diane Sidebottom, ARPA-H Director of Acquisition and Contracts. Learn more about your ad choices. Visit megaphone.fm/adchoices

So far, no FAR: A look inside one agency's unique procurement shop

health unique shop contracts acquisition procurement look inside advanced research projects agency arpa h one agency federal acquisition regulation

Play Episode Listen Later Sep 14, 2023 23:47

Imagine a federal procurement shop where you use every technique, except the Federal Acquisition Regulation. And you don't do grants, either. And you've got congressional backing for your novel approach. That's the case for one of the government's newer agencies, the Advanced Research Projects Agency for Health, known as ARPA-H. For a look on the inside, Federal Drive Host Tom Temin spoke with Diane Sidebottom, ARPA-H Director of Acquisition and Contracts. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ensuring Continuity of Care Following a Cyberattack: ARPA-H Launches Project to Enhance Cybersecurity Tools for Health Care Organizations

K&L Gates Health Care Triage

Play Episode Listen Later Sep 8, 2023 13:07

In this episode, Rebecca Schaefer and Martin Folliard discuss cybersecurity threats faced by health care organizations and a new federal research agency initiative to help create security tools to protect the US health care system from cyberattacks.

project tools healthcare cybersecurity organizations launches enhance ensuring cyberattacks continuity arpa arpa h

Conversations on HC: Have a Way to Beat an Illness? These Federal Experts Need to Hear From You

HealthcareNOW Radio - Insights and Discussion on Healthcare, Healthcare Information Technology and More

Play Episode Listen Later Aug 27, 2023 29:00

On location at Aspen Ideas-Health, hosts Mark Masselli and Margaret Flinter talking with the leaders of a new innovation effort. Advanced Research Projects Agency for Health (ARPA-H) is backed by $2.5 billion dollars in federal money with a mandate to accelerate better health outcomes for everyone. The initiative aims to work outside of traditions with a “range of performers and a variety of approaches to solve” health care's biggest hurdles. Can they find a way to reduce cancer deaths? That's one of the questions Masselli and Flinter ask Renee Wegrzyn, ARPA-H's director and Amy Jenkins, its director of Health Science Futures. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

conversations federal illness smart device advanced research projects agency arpa h mark masselli margaret flinter

Storm⚡️Watch - 8/21/23

Stormâš¡ï¸Watch by GreyNoise Intelligence

Play Episode Listen Later Aug 21, 2023 42:15

In this episode of Storm Watch, the hosts discuss their experiences at Hacker Summer Camp and their excitement about new sensors they've been working with. They consider the possibility of doing a demo in the next episode and mention some sneak peeks available on Andrew's Twitter account. The conversation then shifts to the extreme weather conditions they've been experiencing, including heat domes and "her quakes." The hosts express their disappointment with the lack of progress made by federal departments and agencies in response to the Biden-Harris administration's executive order on cybersecurity. They emphasize the importance of faster reporting and applying basic cybersecurity principles. They also discuss the massive number of victims affected by the "Move It" ransomware, urging cybersecurity professionals to focus on healthcare and other underserved areas. The ARPA-H initiative, or "DigiHeals," is introduced as a government research project aimed at improving healthcare cybersecurity. The hosts share their concerns about the vulnerabilities they've observed in healthcare networks and encourage cybersecurity professionals to dedicate time to helping these critical systems. They also announce the winners of the first annual inaugural Noise Fest CTF of 2023, a Capture the Flag competition organized by the GreyNoise Labs team. Learn more about GreyNoise >>

cybersecurity hacking flag capture biden harris citrix threat intelligence move it stormwatch arpa h hacker summer camp

#358: DARPA's Dangerous Family Tree

Macroaggressions

Play Episode Listen Later Aug 9, 2023 67:54

From its beginnings in 1958 as the Advanced Research Projects Agency to the eventual folding into the Department of Defense in 1972 under its current acronym, DARPA has always been on the cutting edge of technological advancements in the fields of aerospace, defense, computing, and intelligence gathering. These days DARPA is best known for scary robot dogs and brain implants, but the United States government has big plans for expanding the concept of advanced research with “High-risk, High-reward” expectations into the health industry with the creation of ARPA-H in 2022 to take the medical industry where DARPA took the defense contractors. Prepare to be terrified of where this technology is headed and who ultimately has control over its usage, because the robot dogs of your nightmares are only the beginning. Freeworld NYC 9/11 Live Event Tickets: https://www.eventbrite.com/e/free-world-nyc-tickets-667727369537 American Liberty Awards: www.americanlibertyawards.com Christian Yordanov's Detoxification Program: https://members.christianyordanov.com/detox-workshop?coupon=MACRO Sponsors: Emergency Preparedness Food: www.preparewithmacroaggressions.com Chemical Free Body: https://www.chemicalfreebody.com Promo Code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold True Hemp Science: https://truehempscience.com/ Haelan: https://haelan951.com/pages/macro Solar Power Lifestyle: https://solarpowerlifestyle.com/ Promo Code: MACRO LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO Coin Bit App: https://coinbitsapp.com/?ref=0SPP0gjuI68PjGU89wUv Macroaggressions Merch Store: https://www.teepublic.com/stores/macroaggressions?ref_id=22530 LinkTree: linktr.ee/macroaggressions Books: HYPOCRAZY: https://amzn.to/3VsPDp8 Controlled Demolition on Amazon: https://amzn.to/3ufZdzx The Octopus Of Global Control: Amazon: https://amzn.to/3VDWQ5c Barnes & Noble: https://bit.ly/39vdKeQ Online Connection: Link Tree: https://linktr.ee/Macroaggressions Instagram: https://www.instagram.com/macroaggressions_podcast/ Discord Link: https://discord.gg/4mGzmcFexg Website: www.theoctopusofglobalcontrol.com Facebook: www.facebook.com/theoctopusofglobalcontrol Twitter: www.twitter.com/macroaggressio3 Twitter Handle: @macroaggressio3 YouTube: www.youtube.com/channel/UCn3

united states amazon defense dangerous silver noble family tree darpa macroaggressions advanced research projects agency arpa h empshield haelan

Have a Way to Beat an Illness? These Federal Experts Need to Hear From You

Play Episode Listen Later Jul 27, 2023 29:00

We're on location at Aspen Ideas-Health, talking with the leaders of a new innovation effort. Advanced Research Projects Agency for Health (ARPA-H) is backed by $2.5 billion dollars in federal money with a mandate to accelerate better health outcomes for everyone. The initiative aims to work outside of traditions with a “range of performers and a variety of approaches to solve” health care's biggest hurdles. Can they find a way to reduce cancer deaths? That's one of the questions hosts Mark Masselli and Margaret Flinter ask Renee Wegrzyn, ARPA-H's director and Amy Jenkins, its director of Health Science Futures. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

federal illness advanced research projects agency arpa h mark masselli margaret flinter

Have a Way to Beat an Illness? These Federal Experts Need to Hear From You

Play Episode Listen Later Jul 27, 2023 29:00

We're on location at Aspen Ideas-Health, talking with the leaders of a new innovation effort. Advanced Research Projects Agency for Health (ARPA-H) is backed by $2.5 billion dollars in federal money with a mandate to accelerate better health outcomes for everyone. The initiative aims to work outside of traditions with a “range of performers and a variety of approaches to solve” health care's biggest hurdles. Can they find a way to reduce cancer deaths? That's one of the questions hosts Mark Masselli and Margaret Flinter ask Renee Wegrzyn, ARPA-H's director and Amy Jenkins, its director of Health Science Futures.

federal illness advanced research projects agency arpa h mark masselli margaret flinter

Dr. Ross Uhrich, DMD, MBA - Program Manager, Advanced Research Projects Agency for Health (ARPA-H) - Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO)

joe biden state of the union new american arpa arpa h

Play Episode Listen Later Jul 21, 2023 27:49

Dr. Ross Uhrich, DMD, MBA, is Program Manager, Advanced Research Projects Agency for Health ( ARPA-H - https://arpa-h.gov/people/ross-uhrich/ ), which is focused on advancing high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity, accelerating better health outcomes targeting society's most challenging health problems. Under the ARPA-H portfolio, Dr. Uhrich is responsible for the recently launched Novel Innovations for Tissue Regeneration in Osteoarthritis ( NITRO - https://arpa-h.gov/engage/programs/nitro/ ) program which seeks to develop new ways of helping the human body repair its own joints, with the goal of revolutionizing treatment for osteoarthritis — a common and often very painful condition where bones and cartilage break down. Dr. Uhrich joined ARPA-H in March 2023 from Walter Reed National Military Medical Center (WRNMMC) and the Uniformed Services University of the Health Sciences, where he worked as a board-certified oral and maxillofacial surgeon and assistant professor of surgery. In addition to these roles, he spent 12 years with the U.S. Navy, finishing his tenure as a Lieutenant Commander. Throughout his career, Dr. Uhrich has cared for thousands of members of the U.S. Armed Forces at various healthcare facilities, including the USS Gerald R. Ford , Naval Health Clinic Quantico, and WRNMMC, and served as an oral and maxillofacial surgery consultant to Congress. He also treated patients at Charleston Area Medical Center, R Adams Cowley Shock Trauma Center, and Suburban Hospital. Dr. Uhrich holds a doctorate in dental medicine from the University of Pennsylvania, an MBA from the University of Virginia, and completed his surgical residency at WRNMMC. He also has a Bachelor of Science in Biomedical Engineering from Yale University. Support the show

Meet Dr. Renee Wegrzyn, the First Director of President Biden's New Health Agency, ARPA-H

Making Sense of Science

Play Episode Listen Later May 31, 2023 45:01

In today's podcast episode, I talk with Renee Wegrzyn, appointed by President Biden as the first director of a federal agency created last year called the Advanced Research Projects Agency for Health, or ARPA-H. It's inspired by DARPA, the agency that develops innovations for the Defense department and has been credited with hatching world changing technologies such as ARPANET, which became the internet.Time will tell if ARPA-H will lead to similar achievements in the realm of health. That's what President Biden and Congress expect in return for funding ARPA-H at 2.5 billion dollars over three years. How will the agency figure out which projects to take on, especially with so many patient advocates for different diseases demanding moonshot funding for rapid progress. I talked with Dr. Wegrzyn about the opportunities and challenges, what lessons ARPA-H is borrowing from Operation Warp Speed, how she decided on the first ARPA-H project which was just announced recently, why a separate agency was needed instead of trying to reform HHS and the National Institutes of Health to be better at innovation, and how ARPA-H will make progress on disease prevention in addition to treatments for cancer, Alzheimer's and diabetes, among many other health priorities.Dr. Wegrzyn's resume is filled with experience for her important role. She was a program manager at DARPA where she focused on applying gene editing and synthetic biology to the goal of improving biosecurity. For her work there, she was given the Superior Public Service Medal and, just in case that wasn't enough ARPA experience, she also worked at another ARPA that leads advanced projects in intelligence, called I-ARPA. Before that, she was in charge of technical teams in the private sector working on gene therapies and disease diagnostics, among other areas. She has been a vice president of business development at Gingko Bioworks and headed innovation at Concentric by Gingko. Her training and education includes a PhD and undergraduate degree in applied biology from the Georgia Institute of Technology and she did her postdoc as an Alexander von Humboldt Fellow in Heidelberg, Germany.As Dr. Wegrzyn told me, she's “in the hot seat” - the pressure is on for ARPA-H especially after the need and potential for health innovation was spot lit by the pandemic and the unprecedented speed of vaccine development. We'll soon find out if ARPA-H can produce something in health that's equivalent to DARPA's creation of the internet.Show links:ARPA-H - https://arpa-h.gov/Dr. Wegrzyn profile - https://arpa-h.gov/people/renee-wegrzyn/Dr. Wegrzyn Twitter - https://twitter.com/rwegrzyn?lang=enPresident Biden Announces Dr. Wegrzyn's appointment - https://www.whitehouse.gov/briefing-room/statements-releases/2022/09/12/president-biden-announces-intent-to-appoint-dr-renee-wegrzyn-as-inaugural-director-of-advanced-research-projects-agency-for-health-arpa-h/Leaps.org coverage of ARPA-H - https://leaps.org/arpa/ARPA-H program for joints to heal themselves - https://arpa-h.gov/news/nitro/ - ARPA-H virtual talent search - https://arpa-h.gov/news/aco-talent-search/Leaps.org is a not-for-profit initiative that publishes award-winning journalism, popularizes scientific progress on social media, and hosts events about bioethics and the future of humanity. Visit the platform at www.leaps.org. Podcast host Matt Fuchs is editor-in-chief of Leaps.org.

ARPA-H

The Daniel Natal Show

Play Episode Listen Later Feb 15, 2023 8:25

The government has weaponized healthcare with a program they call ARPA-H. Biden mentioned it in his State of the Union address. See what it means for the future ahead. DISCLAIMER: Views and opinions expressed on The Daniel Natal Show are solely those of the host and do not necessarily represent those of The New American. ... The post ARPA-H appeared first on The New American.

Dr. Renee Wegrzyn, Ph.D. - ARPA-H - Transformative, Sustainable, Equitable Health Solutions For All

director health research medicine healthcare transform national institutes accelerating arpa stanford school advanced research projects agency arpa h

Play Episode Listen Later Feb 7, 2023 25:30

Dr. Renee Wegrzyn, Ph.D. is the inaugural director of the Advanced Research Projects Agency for Health ( ARPA-H - https://arpa-h.gov/ ), an agency that supports the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone. ARPA-H's mission focuses on leveraging research advances for real world impact. Previously, Dr. Wegrzyn served as a vice president of business development at Ginkgo Bioworks and head of Innovation at Concentric by Ginkgo, where she focused on applying synthetic biology to outpace infectious diseases—including Covid-19—through biomanufacturing, vaccine innovation and biosurveillance of pathogens at scale. Prior to Ginkgo, Dr. Wegrzyn was program manager in the Biological Technologies Office at DARPA, where she leveraged the tools of synthetic biology and gene editing to enhance biosecurity, promote public health and support the domestic bioeconomy. Her DARPA portfolio included the Living Foundries: 1000 Molecules, Safe Genes, Preemptive Expression of Protective Alleles and Response Elements and the Detect it with Gene Editing Technologies programs. Dr. Wegrzyn received the Superior Public Service Medal for her work and contributions at DARPA. Prior to joining DARPA, she led technical teams in private industry in the areas of biosecurity, gene therapies, emerging infectious disease, neuromodulation, synthetic biology, as well as research and development teams commercializing multiplex immunoassays and peptide-based disease diagnostics. Dr. Wegrzyn holds doctorate and bachelor's degrees in applied biology from the Georgia Institute of Technology. She was a fellow in the Center for Health Security Emerging Leaders in Biosecurity Initiative and completed postdoctoral training as an Alexander von Humboldt fellow in Heidelberg, Germany. Support the show

S3 Ep8: ARPA-H Director Renee Wegrzyn On Accelerating Research To Transform Health Care

The Minor Consult

Play Episode Listen Later Feb 2, 2023 44:55

In this special episode in front of a live audience at the Stanford School of Medicine, Dean Lloyd Minor welcomes Renee Wegrzyn, inaugural director of the Advanced Research Projects Agency for Health, known as ARPA-H, within the National Institutes of Health. They explore Renee's vision and roadmap for the new agency, which was established in 2022 with the mission of accelerating high-impact research to drive transformative solutions in health and health care. Renee outlines the agency's model for rapidly developing groundbreaking innovations and how her experience at the Defense Advanced Research Projects Agency informs her leadership of ARPA-H. She also discusses the importance of public-private collaborations, leveraging sophisticated technological platforms, and engaging diverse perspectives in advancing breakthroughs to address the most pressing challenges for patients and communities.

Fostering Respect for Science and Support for Health Innovation - Max Bronstein, Assistant Director of the White House Office of Science and Technology Policy

Raise the Line

Play Episode Listen Later Jan 11, 2023 34:58

The growth in skepticism about science that was fueled by disinformation during the pandemic has been a frequent topic on Raise the Line, with many insightful guests from medicine and academia offering analysis of the problem and possible solutions. On today's episode, we'll hear from someone who is very well-placed to actually make progress on this front. Max Bronstein, the Assistant Director for Health Innovation at the White House Office of Science and Technology Policy, joins host Shiv Gaglani to discuss the broad support President Biden has provided for science – elevating his science advisor to the cabinet level being a prime example – and also provide details about programmatic investments that tell the tale at a deeper level. At the top of Bronstein's list of examples is the launch of the Advanced Research Projects Agency for Health, also known as ARPA-H, which aims to drive transformative biomedical and health breakthroughs with a focus on equity. “The mission is about making sure there are cures for diseases, better diagnostic platforms and better technologies out there, but also making sure those are actually available to all Americans.” Don't miss this inside look at new efforts to strengthen the biotechnology workforce, broaden access to clinical genetic sequencing, advance development of treatments for rare diseases, and much more as a new era in health innovation gets underway. Mentioned in this episode: https://www.whitehouse.gov/ostp/

Bill Gates on "'Hung' Midterms & Civil War," Communist Left Embrace Perversity, Biosurveillance Next | The Hagmann Report 9/27/2022

Play Episode Listen Later Sep 27, 2022 60:01

Biden via his handlers: "Nice pipeline ya got there. It would be a shame if something happened to it!"As difficult as it might be to believe, the Biden regime - or those behind him, propping him like "Weekend at Bernies," have clearly stated as their goal to facilitate (via executive order and funding) to “write circuitry for cells and predictably program biology in the same way in which we write software and program computers.”As pointed out by Joe Allen in his substack article, '[o]ne day after signing his transhuman executive order, the obviously unenhanced Joe Biden announced that Renee Wegryzn will be the inaugural director of the new agency ARPA-H—the Advanced Research Projects Agency for Health. The agency is slated to receive $1 billion at present, although Biden is pushing for a stunning $6.5 billion."We are being fast-tracked to become largely tranhumanistic and subservient to the globalists (or dead). One big step is via the economy. In this episode, Doug Hagmann provides the details.IMPORTANT LINKS:DONATE: (www.HagmannReport.com/donate)HAGMANN COFFEE & MORE: (www.HagmannStore.com)The Hagmann Report provides news and information based on a combination of exclusive investigative work, proprietary sources, contacts, qualified guests, open-source material. The Hagmann Report will never be encumbered by political correctness or held hostage to an agenda of revisionist history.Join Doug Hagmann, host of the Hagmann Report, Weekdays @ 7 PM ET.ON THE GO? SUBSCRIBE TO HAGMANN'S PODCASTiTunes: (https://podcasts.apple.com/us/podcast/hagmann-report/id631558915?uo=4)Spotify: (https://open.spotify.com/show/376mkckQHCPYTJssQN794g)iHeart: (https://www.iheart.com/podcast/256-hagmann-report-30926499/)Spreaker: (https://www.spreaker.com/show/hagmann-report)Email: studio@hagmannreport.comFOLLOW HAGMANN AT:Parler: https://parler.com/DouglasHagmannGab: https://gab.com/DougHagmannGettr: https://gettr.com/user/doughagmannTruth Social: https://truthsocial.com/@DougHagmannTwitter: Twitter is garbage

spotify health joe biden left embrace civil war bill gates midterms communists spreaker joe allen bernies on the go perversity advanced research projects agency arpa h doug hagmann hagmann report

Bill Gates on "'Hung' Midterms & Civil War," Communist Left Embrace Perversity, Biosurveillance Next | The Hagmann Report 9/27/2022

Play Episode Listen Later Sep 27, 2022 60:01

Biden via his handlers: "Nice pipeline ya got there. It would be a shame if something happened to it!"As difficult as it might be to believe, the Biden regime - or those behind him, propping him like "Weekend at Bernies," have clearly stated as their goal to facilitate (via executive order and funding) to “write circuitry for cells and predictably program biology in the same way in which we write software and program computers.”As pointed out by Joe Allen in his substack article, '[o]ne day after signing his transhuman executive order, the obviously unenhanced Joe Biden announced that Renee Wegryzn will be the inaugural director of the new agency ARPA-H—the Advanced Research Projects Agency for Health. The agency is slated to receive $1 billion at present, although Biden is pushing for a stunning $6.5 billion."We are being fast-tracked to become largely tranhumanistic and subservient to the globalists (or dead). One big step is via the economy. In this episode, Doug Hagmann provides the details.IMPORTANT LINKS:DONATE: (www.HagmannReport.com/donate)HAGMANN COFFEE & MORE: (www.HagmannStore.com)The Hagmann Report provides news and information based on a combination of exclusive investigative work, proprietary sources, contacts, qualified guests, open-source material. The Hagmann Report will never be encumbered by political correctness or held hostage to an agenda of revisionist history.Join Doug Hagmann, host of the Hagmann Report, Weekdays @ 7 PM ET.ON THE GO? SUBSCRIBE TO HAGMANN'S PODCASTiTunes: (https://podcasts.apple.com/us/podcast/hagmann-report/id631558915?uo=4)Spotify: (https://open.spotify.com/show/376mkckQHCPYTJssQN794g)iHeart: (https://www.iheart.com/podcast/256-hagmann-report-30926499/)Spreaker: (https://www.spreaker.com/show/hagmann-report)Email: studio@hagmannreport.comFOLLOW HAGMANN AT:Parler: https://parler.com/DouglasHagmannGab: https://gab.com/DougHagmannGettr: https://gettr.com/user/doughagmannTruth Social: https://truthsocial.com/@DougHagmannTwitter: Twitter is garbage

spotify health politics news joe biden left embrace civil war bill gates current events midterms alex jones communists insurrection spreaker deep state election 2020 sean hannity infowars j6 john moore joe allen bernies on the go perversity steve quayle stan deyo advanced research projects agency arpa h hagmann doug hagmann hagmann report thelibertyman

Economic Collapse, Digital Currency & Digital ID- We Must Be the Drivers of Resistence | Doug Hagmann | The Hagmann Report 9/20/2022

Play Episode Listen Later Sep 20, 2022 60:01

As difficult as it might be to believe, the Biden regime - or those behind him, propping him like "Weekend at Bernies," have clearly stated as their goal to facilitate (via executive order and funding) to “write circuitry for cells and predictably program biology in the same way in which we write software and program computers.”As pointed out by Joe Allen in his substack article, '[o]ne day after signing his transhuman executive order, the obviously unenhanced Joe Biden announced that Renee Wegryzn will be the inaugural director of the new agency ARPA-H—the Advanced Research Projects Agency for Health. The agency is slated to receive $1 billion at present, although Biden is pushing for a stunning $6.5 billion."We are being fast-tracked to become largely tranhumanistic and subservient to the globalists (or dead). One big step is via the economy. In this episode, Doug Hagmann provides the details.IMPORTANT LINKS:DONATE: (www.HagmannReport.com/donate)HAGMANN COFFEE & MORE: (www.HagmannStore.com)The Hagmann Report provides news and information based on a combination of exclusive investigative work, proprietary sources, contacts, qualified guests, open-source material. The Hagmann Report will never be encumbered by political correctness or held hostage to an agenda of revisionist history.Join Doug Hagmann, host of the Hagmann Report, Weekdays @ 7 PM ET.ON THE GO? SUBSCRIBE TO HAGMANN'S PODCASTiTunes: (https://podcasts.apple.com/us/podcast/hagmann-report/id631558915?uo=4)Spotify: (https://open.spotify.com/show/376mkckQHCPYTJssQN794g)iHeart: (https://www.iheart.com/podcast/256-hagmann-report-30926499/)Spreaker: (https://www.spreaker.com/show/hagmann-report)Email: studio@hagmannreport.comFOLLOW HAGMANN AT:Parler: https://parler.com/DouglasHagmannGab: https://gab.com/DougHagmannGettr: https://gettr.com/user/doughagmannTruth Social: https://truthsocial.com/@DougHagmannTwitter: Twitter is garbage

Economic Collapse, Digital Currency & Digital ID- We Must Be the Drivers of Resistence | Doug Hagmann | The Hagmann Report 9/20/2022